• Mashup Score: 1
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Source: lww.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncologyTimes
      OncologyTimes

      A #study showed a crucial need to improve frontline therapy strategies for treating #MyelodysplasticSyndromes. #Scientists are proposing a strategy for early intervention to enhance treatment outcomes for patients diagnosed with #MDS: https://t.co/U0fvTPCapB https://t.co/ujWJvrWCpO

  • Mashup Score: 1
    MDS Sessions: iwMDS 2022 - 2 year(s) ago

    Watch our exclusive roundtable discussions from iwMDS 2022 with leading experts in the field, who cover several topics and share their highlights.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      If you missed out on #iwMDS2022, don't worry! You can catch up with all expert-led roundtable discussions with our latest session🤩 ➡️https://t.co/LiQadCDfXJ⬅️ #MDSsm #MyelodysplasticSyndromes #LeuSM #AMLsm #HemOnc https://t.co/dCKfZHVdbU

  • Mashup Score: 0
    IPSS-R vs IPSS-M for MDS - 2 year(s) ago

    David Sallman, MD, Moffitt Cancer Center, Tampa, FL, outlines the caveats of the Revised International Prognostic Scoring System (IPSS-R) for…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      David Sallman (@MoffittNews) discusses IPSS-R versus IPSS-M in the prognosis of myelodysplastic syndromes. Watch his interview here: 👉https://t.co/UUazXhqTQy👈 @EHA_Hematology #EHA2022 #HemOnc #MDSsm #MyelodysplasticSyndromes

  • Mashup Score: 2
    Ivosidenib in patients with IDH1-mutant MDS - 2 year(s) ago

    David Sallman, MD, University of Texas MD Anderson Cancer Center, Houston, TX, shares the results of the dose-escalation and expansion…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      David Sallman (@MDAndersonNews) shares some updates from a study evaluating ivosidenib in patients with IDH1-mutant MDS: 👉https://t.co/qqgRmpQGeL👈 @EHA_Hematology #EHA2022 #HemOnc #MDSsm #MyelodysplasticSyndromes

  • Mashup Score: 2
    The impact of AI and machine learning algorithms in MDS - 2 year(s) ago

    Artificial intelligence (AI) and machine learning algorithms are transforming treatment and prognosis in hematological malignancies, as well as other areas…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      We're pleased to bring you our latest podcast! Join leading experts as they discuss the impact of artificial intelligence and machine learning in the treatment of MDS: 🎧: https://t.co/LGi8kRDnP5 #MDSsm #MyelodysplasticSyndromes

  • Mashup Score: 8
    MDS Sessions: The impact of AI in MDS | VJHemOnc - 2 year(s) ago

    A session with experts Amer Zeidan, Aziz Nazha, and Anne Sophie Kubasch, who discuss the impact of artificial intelligence and machine learning in MDS.

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      📣Join leading experts @Dr_AmerZeidan, @ASKubasch & @AzizNazhaMD as they hold a fascinating discussion on the impact of artificial intelligence and machine learning in MDS. Watch this exclusive session here: 👉https://t.co/dExvv5IcCw👈 #MDSsm #MyelodysplasticSyndromes https://t.co/Cxo3mSRq4M

  • Mashup Score: 1
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Source: lww.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncologyTimes
      OncologyTimes

      Recent advances in molecular genetic diagnostics have improved our understanding of the pathogenesis of #Myelodysplasticsyndromes. We discuss several agents with unique mechanisms that may advance the treatment of #MDS after years of stagnancy: https://t.co/ujjJUyqCK3 #HemOnc https://t.co/KzRnmUR2Zz

Load More